CNBC 快讯 5月12日 17:07 新型GLP-1标的涨势凌厉，UBS看涨近50%空间 This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here MBX Biosciences has rallied more than 230% over the past year, but there's room for still more upside from current level… FG 100 读报告 →